Trajectories of Adherence to Low-Dose Aspirin Treatment Among the French Population

被引:9
作者
Ajrouche, Aya [1 ]
Estellat, Candice [1 ]
De Rycke, Yann [1 ]
Tubach, Florence [1 ]
机构
[1] Sorbonne Univ, Fac Med, Hop Pitie Salpetriere,INSERM,UMR 1123,ECEVE,CIC P, AP HP,Dept Biostat Sante Publ & Informat Med,Ctr, Paris, France
关键词
aspirin; adherence; group-based trajectory modeling; SNDS; pharmacoepidemiology; population-based study; AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; MEDICATION ADHERENCE; MYOCARDIAL-INFARCTION; SCIENTIFIC STATEMENT; SAS PROCEDURE; OLDER-ADULTS; CORONARY; MODELS;
D O I
10.1177/1074248419865287
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies have shown that adherence to low-dose aspirin (LDA) is suboptimal. However, these studies were based on an average measure of adherence during follow-up, ignoring its dynamic process over time. We described the trajectories of adherence to LDA treatment among the French population over 3 years of follow-up. Methods: We identified a cohort of 11 793 new LDA users, aged >= 50 years in 2010, by using the French national health-care database. Patients included had at least 3 years of history in the database before study entry to exclude prevalent aspirin users and to assess baseline comorbidities. They were followed from the first date of LDA supply (the index date) until the first date among death, exit from the database, or 3 years after the index date. Adherence to LDA was assessed every 3 months by using the proportion of days covered (PDC) and dichotomized with a cutoff of PDC of 0.8. We used group-based trajectory modeling to identify trajectories of LDA adherence. Predictors of LDA adherence trajectory membership were identified by multinomial logistics regression. Results: We identified 4 trajectories of adherence among new LDA users: the not-adherents (4737 [40.2%]), the delayed not-adherents (gradual decrease in adherence probability, 1601 [13.6%]), the delayed adherents (gradual increase in adherence probability, 1137 [9.6%]), and the persistent adherents (4318 [36.6%]). The probability of belonging to the not-adherent group was increased with female sex, low socioeconomic status, and polymedication and was reduced with a secondary indication for LDA use, such as diabetes, hypertension, and dementia, at least 4 consultations in the previous year, or 1 hospitalization or a cardiologist consultation in the 3 months before the index date. Conclusion: This study provides a dynamic picture of adherence behaviors among new LDA users and underlines the presence of critical trajectories that intervention could target to improve adherence.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 49 条
[41]   AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute [J].
Smith, Sidney C., Jr. ;
Allen, Jerilyn ;
Blair, Steven N. ;
Bonow, Robert O. ;
Brass, Lawrence M. ;
Fonarow, Gregg C. ;
Grundy, Scott M. ;
Hiratzka, Loren ;
Jones, Daniel ;
Krumholz, Harlan M. ;
Mosca, Lori ;
Pasternak, Richard C. ;
Pearson, Thomas ;
Pfeffer, Marc A. ;
Taubert, Kathryn A. .
CIRCULATION, 2006, 113 (19) :2363-2372
[42]   The assessment of refill compliance using pharmacy records: Methods, validity, and applications [J].
Steiner, JF ;
Prochazka, AV .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (01) :105-116
[43]   Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events A Swedish Nationwide, Population-Based Cohort Study [J].
Sundstroem, Johan ;
Hedberg, Jakob ;
Thuresson, Marcus ;
Aarskog, Pernilla ;
Johannesen, Kasper Munk ;
Oldgren, Jonas .
CIRCULATION, 2017, 136 (13) :1183-+
[44]   French national health insurance information system and the permanent beneficiaries sample [J].
Tuppin, P. ;
de Roquefeuil, L. ;
Weill, A. ;
Ricordeau, P. ;
Merliere, Y. .
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2010, 58 (04) :286-290
[45]   Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization [J].
Tuppin, Philippe ;
Neumann, Anke ;
Danchin, Nicolas ;
de Peretti, Christine ;
Weill, Alain ;
Ricordeau, Philippe ;
Allemand, Hubert .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (6-7) :363-375
[46]   Classifying developmental trajectories over time should be done with great caution: a comparison between methods [J].
Twisk, Jos ;
Hoekstra, Trynke .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (10) :1078-1087
[47]   The GRoLTS-Checklist: Guidelines for Reporting on Latent Trajectory Studies [J].
van de Schoot, Rens ;
Sijbrandij, Marit ;
Winter, Sonja D. ;
Depaoli, Sarah ;
Vermunt, Jeroen K. .
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL, 2017, 24 (03) :451-467
[48]  
Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306
[49]  
WHO, 2014, INT CLASS DIS ICD